Latin American Origin Is Not Associated with Worse Outcomes among Hospitalized Patients with COVID-19 in a Public Healthcare System
Por:
Otero-Rodriguez, S, Moreno-Perez, O, Ramos, J, Garcia, M, Boix, V, Reus, S, Torrus, D, Chico-Sanchez, P, Sanchez-Paya, J, Aldana-Macias, F, Gil, J, Portilla, J, Merino, E and COVID19 ALC Res Grp
Publicada:
1 ago 2021
Ahead of Print:
20 ago 2021
Resumen:
Exploring differences in clinical outcomes based on race and origin among patients hospitalized for COVID-19 is a controversial issue. The ALC COVID-19 Registry includes all confirmed COVID-19 patients admitted to hospital from 3 March 2020 to 17 December 2020. The data were obtained from electronic health records in order to evaluate the differences in the clinical features and outcomes among European and Latin American patients. The follow-ups occurred after 156 days. A propensity score weighting (PSW) logistic regression model was used to estimate the odds ratio (OR, 95% CI) for Latin American origin and outcome associations. Of the 696 patients included, 46.7% were women, with a median age of 65 (IQR 53-67) years, 614 (88.2%) were European, and 82 (11.8%) were Latin American. Latin American patients were younger, with fewer comorbidities, and a higher incidence of extensive pneumonia. After adjusting for residual confounders, Latin American origin was not associated with an increased risk of death (PSW OR 0.85 (0.23-3.14)) or with the need for invasive mechanical ventilation (PSW OR 0.35 (0.12-1.03)). Latin American origin was associated with a shorter hospital stay, but without differences in how long the patient remained on mechanical ventilation. In a public healthcare system, the rates of death or mechanical ventilation in severe COVID-19 cases were found to be comparable between patients of European and Latin American origins.
Filiaciones:
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Unit Infect Dis, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Endocrinol & Nutr Dept, Alicante 03013, Spain
Miguel Hernandez Univ, Clin Med Dept, Elche 03202, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Miguel Hernandez Univ, Clin Med Dept, Elche 03202, Spain
Alicante Gen Univ Hosp, Internal Med Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Internal Med Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Unit Infect Dis, Alicante 03010, Spain
Miguel Hernandez Univ, Clin Med Dept, Elche 03202, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Miguel Hernandez Univ, Clin Med Dept, Elche 03202, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Unit Infect Dis, Alicante 03010, Spain
Miguel Hernandez Univ, Parasitol Area, Elche 03202, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Prevent Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Prevent Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Pneumol Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Pneumol Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Miguel Hernandez Univ, Clin Med Dept, Elche 03202, Spain
Alicante Gen Univ Hosp, Internal Med Dept, Alicante 03010, Spain
:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
Alicante Gen Univ Hosp, Unit Infect Dis, Alicante 03010, Spain
COVID19 ALC Res Grp:
Alicante Inst Hlth & Biomed Res ISABIAL, Alicante 03010, Spain
ISABIAL, España.
Green Published
|